Quantum-Si incorporated

NasdaqGM QSI

Quantum-Si incorporated EBT Margin for the Trailing 12 Months (TTM) ending September 30, 2024: -3,966.95%

Quantum-Si incorporated EBT Margin is -3,966.95% for the Trailing 12 Months (TTM) ending September 30, 2024, a 74.73% change year over year. EBT Ratio (Earnings Before Tax Ratio) is the fraction of earnings before taxes to total revenue, indicating the company's profitability before the impact of tax expenses.
  • Quantum-Si incorporated EBT Margin for the Trailing 12 Months (TTM) ending September 30, 2023 was -15,696.77%.
Key data
Date EBT Margin Net Income Margin EBITDA Margin EBIT Margin
Market news
Loading...
NasdaqGM: QSI

Quantum-Si incorporated

CEO Mr. Jeffrey Alan Hawkins
IPO Date Nov. 13, 2020
Location United States
Headquarters 530 Old Whitfield Street
Employees 159
Sector Health Care
Industries
Description

Quantum-Si incorporated, a life sciences company, develops a single molecule detection platform for sample preparation and sequencing. It offers a proprietary single molecule detection platform for use in semiconductor industry to field proteomics to enable next generation protein sequencing. The company was incorporated in 2013 is based in Guilford, Connecticut.

Similar companies

SEER

Seer, Inc.

USD 2.29

-1.29%

RNA

Avidity Biosciences, Inc.

USD 27.05

-4.79%

NRIX

Nurix Therapeutics, Inc.

USD 18.60

-2.16%

PRME

Prime Medicine, Inc.

USD 2.70

-2.53%

MNOV

MediciNova, Inc.

USD 1.91

-4.02%

VERV

Verve Therapeutics, Inc.

USD 5.25

-4.54%

HRTX

Heron Therapeutics, Inc.

USD 1.47

-4.54%

BDTX

Black Diamond Therapeutics, Inc.

USD 2.25

-2.60%

HOOK

HOOKIPA Pharma Inc.

USD 1.86

4.49%

NTLA

Intellia Therapeutics, Inc.

USD 9.74

-3.08%

EDIT

Editas Medicine, Inc.

USD 1.14

-1.72%

BEAM

Beam Therapeutics Inc.

USD 23.30

-8.77%

CRBU

Caribou Biosciences, Inc.

USD 1.56

0.65%

ALEC

Alector, Inc.

USD 1.64

-8.38%

ABOS

Acumen Pharmaceuticals, Inc.

USD 1.56

-1.89%

CRSP

CRISPR Therapeutics AG

USD 38.36

-1.26%

StockViz Staff

January 15, 2025

Any question? Send us an email